tiprankstipranks
Trending News
More News >

Entheon Biomedical Ends Acquisition Agreement with Mentis AI

Story Highlights
Entheon Biomedical Ends Acquisition Agreement with Mentis AI

Confident Investing Starts Here:

Entheon Biomedical ( (TSE:ENBI) ) just unveiled an announcement.

Entheon Biomedical Corp. announced the termination of its agreement with Mentis AI, which involved acquiring all common shares of the latter. This development may impact Entheon’s strategic plans in the biotechnology sector, particularly in its focus on addiction treatment, and could have implications for stakeholders involved in the proposed acquisition.

More about Entheon Biomedical

Entheon Biomedical Corp. is a biotechnology research and development company focused on treating addiction and substance use disorders.

YTD Price Performance: -53.57%

Average Trading Volume: 3,038

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $1.73M

Find detailed analytics on ENBI stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App